Clarence L. Dellio

78 year

Health Technology

Consumer Services

Profile

Clarence L.
Dellio served as Vice President-Manufacturing at Becton, Dickinson & Co. He then worked as Chief Operating Officer & Senior Vice President at XOMA Corp.
from 1984 to 2004.
From 2004 to 2008, he was the President & Chief Operating Officer at Neosil, Inc. In 2011 to 2013, he served as Chief Operating Officer at Aevi Genomic Medicine, Inc. Mr. Dellio obtained his undergraduate degree from Bentley University.

Former positions of Clarence L. Dellio

Companies	Position	End
AEVI GENOMIC MEDICINE, INC.	Chief Operating Officer	2013-12-30
Neosil, Inc. Neosil, Inc. Pharmaceuticals: MajorHealth Technology Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA.	President	-
XOMA CORPORATION	Chief Operating Officer	2003-12-31
BECTON, DICKINSON AND COMPANY	Corporate Officer/Principal	-

See the detail of Clarence L. Dellio's experience

Training of Clarence L. Dellio

Bentley University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clarence L. Dellio's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
XOMA CORPORATION	Health Technology
BECTON, DICKINSON AND COMPANY	Health Technology

Private companies	2
Neosil, Inc. Neosil, Inc. Pharmaceuticals: MajorHealth Technology Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA.	Health Technology
Aevi Genomic Medicine, Inc. Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.	Health Technology